K-numberK250671
Device nameFreeStyle Comfort (AS200 / FreeStyle Comfort)
ApplicantCaire, Inc.
Product codeCAW
Device classClass II
Decision dateJul 11, 2025
DecisionSubstantially Equivalent
Regulation868.5440
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The FreeStyle Comfort is a portable, lightweight (5-6 lbs) oxygen concentrator that delivers concentrated oxygen (90% ±5.5%/-3%) to patients requiring supplemental oxygen therapy on a prescription basis. It operates via pulse-dose delivery (fixed-minute or autoSAT modes) and can be used in homes, institutions, and during transport, including on commercial aircraft. The device is not intended for life support.

Technological characteristics

Both the subject device and predicate (Inogen Rove 4) use Pressure Swing Adsorption (PSA) technology with dual molecular sieve beds to separate oxygen from nitrogen. Both deliver oxygen as a bolus at the start of inhalation, sense breath-triggered demand, and employ lithium-ion batteries with AC/DC power options. The subject device offers five fixed flow settings plus autoSAT; the predicate offers four fixed settings. Both achieve identical 90% oxygen concentration and deliver via standard nasal cannula.

Test standards cited

ISO 80601-2-69 (oxygen concentrator basic safety and performance), ISO 80601-2-67 (oxygen-conserving equipment), IEC 60601-1 series (medical electrical equipment safety), IEC 62366-1 (usability), ISO 18562-2 and -3 (biocompatibility—particulate matter and volatile organic compounds), and sound testing per ISO 3744.

Substantial equivalence argument

The subject and predicate devices employ identical PSA oxygen separation technology, produce the same oxygen concentration (90%+5.5%/-3%), and deliver oxygen via identical demand-based pulse dosing to the same patient population in identical use environments (home, institution, transport). The differences—larger battery capacity (8/16-cell vs. 4/8-cell), one additional flow setting, and autoSAT capability in the subject device—are enhancements that do not introduce new safety or effectiveness concerns because the fundamental operating principle, oxygen output specification, user interface paradigm, and power/component architecture remain substantially unchanged.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →